Key takeaways

  • The choice is not "medicine vs no risk" — untreated moderate to severe depression carries substantial risks to both mother and baby, including preterm birth, poor bonding and, rarely, suicide.
  • Most antidepressants are not linked to major birth defects. Sertraline and citalopram/escitalopram are generally preferred SSRIs in pregnancy.
  • Paroxetine is usually avoided when alternatives exist; valproate is strongly contraindicated, and lithium needs specialist, closely monitored use.
  • SSRIs in late pregnancy can cause a mild, self-limiting neonatal adaptation syndrome — this is not addiction and usually settles within days to two weeks.
  • Stopping medicine abruptly to "protect the baby" can backfire by triggering relapse. Plan any change with a perinatal psychiatrist.
  • Sertraline is among the safest antidepressants while breastfeeding; most others are also compatible with feeding.

Risks on both sides: the honest frame

Every decision about antidepressants in pregnancy weighs two sets of risks against each other — the risks of the medicine, and the risks of untreated illness. The goal is not zero risk (that option does not exist); it is the most acceptable balance for you, in this pregnancy.

Why untreated depression is not the "safe" option. Moderate to severe depression or anxiety in pregnancy is linked in large studies to preterm birth, low birth weight, restricted fetal growth, and higher rates of pre-eclampsia and gestational diabetes. It raises the risk of postpartum depression, which can affect bonding and a child's later development. Most seriously, untreated maternal mental illness increases the risk of self-harm and suicide — one of the leading causes of maternal death in many countries. The idea that "avoiding tablets keeps the baby safe" simply ignores this side of the ledger.

Why most antidepressants are reassuring. Across two decades of cohort studies and meta-analyses, antidepressants as a class show only small to modest links with specific outcomes — none show large or catastrophic effects, and the absolute increase in risk is usually small. The well-known teratogenic dangers come from a few specific drugs (valproate, lithium for one rare heart defect, paroxetine in some studies), not from antidepressants in general.

The decision is individual and shared. It depends on how severe your illness is, how badly you have relapsed before, which medicine you take, what alternatives exist, where you are in the pregnancy, and your own values. It is best made jointly with a perinatal psychiatrist and your obstetrician, and it can be revisited as your pregnancy progresses. Emotional preparation matters too — our guide on how pregnancy isn't always easy walks through this honestly.

SSRIs in pregnancy: the most-used and best-studied class

Which SSRI? The usual hierarchy

Sertraline (Zoloft, Daxid, Serlift) — generally the preferred SSRI in pregnancy and breastfeeding, with the most favourable evidence base. Endorsed as a first-line consideration by major bodies and Indian perinatal services. Roughly ₹100–400 a month.

Citalopram (Cipram, Citopam) and escitalopram (Nexito, Cipralex) — also considered relatively safer and often used first-line alongside sertraline. Citalopram has an FDA dose ceiling of 40 mg/day (QT-prolongation concern at higher doses). About ₹80–500 a month.

Fluoxetine (Prozac, Fludac) — the original SSRI, long track record and large data set, generally acceptable. Its very long half-life means it lingers for weeks, which affects timing if you change medicines.

Paroxetine (Paxil, Pexep, Xet) — usually avoided when alternatives exist. Early studies (around 2005–07) flagged a small increased risk of cardiac defects with first-trimester exposure; later results are mixed but the caution remains. A woman already stable on it faces an individual choice about switching, ideally before or early in pregnancy.

Switching, dosing and timing

Switching from paroxetine to sertraline or citalopram is sometimes done before conception or in early pregnancy — but switching means stopping something that works, which itself risks relapse, so it belongs with a psychiatrist.

Dosing can shift during pregnancy. Greater blood volume, altered protein binding and faster clearance mean some women find their usual dose becomes less effective later on — a reason for ongoing follow-up rather than "set and forget".

Timing matters two ways: the first trimester is the window for organ formation, and the third trimester is when neonatal adaptation and PPHN concerns apply. Some clinicians modestly lower the dose near term to reduce neonatal effects, balanced against the risk of relapse just before delivery. There is no single right answer — this is individualised.

Other antidepressant classes

When SSRIs have not worked or were poorly tolerated, other options exist, each with its own evidence base.

  • SNRIs — venlafaxine (Effexor, Venlor) and duloxetine (Cymbalta, Duloxin), useful when anxiety or pain is prominent. Smaller pregnancy data than SSRIs but broadly reassuring; similar late-pregnancy neonatal considerations.
  • Tricyclics (TCAs) — amitriptyline (Tryptomer), nortriptyline (Sensival), imipramine. A long history of use; generally acceptable, though anticholinergic side effects can be troublesome. Nortriptyline is often preferred within the class.
  • Bupropion (Wellbutrin, Bupron) — atypical, also used for smoking cessation. Moderate evidence, generally acceptable; an early signal of a small ADHD link has not been consistently confirmed.
  • Mirtazapine (Remeron, Mirtaz) — atypical, helpful when sedation, appetite or weight gain are wanted. Moderate evidence, generally acceptable when indicated.
  • MAOIs, vortioxetine, agomelatine — generally avoided in pregnancy because of limited safety data or significant interactions, when better-studied options exist.

The guiding principle: when an SSRI (especially sertraline or citalopram) has been effective and tolerated, it is usually the first choice. Your previous response to a medicine is weighted heavily — if one drug worked well for you before, that is a strong reason to continue or restart it.

Medicines to avoid or use only with great care

A few psychiatric medicines carry high enough teratogenic risk that they are contraindicated or strongly cautioned in pregnancy. These are mostly mood stabilisers and sedatives rather than antidepressants — but they matter because they are sometimes used for bipolar disorder or alongside an antidepressant.

  • Valproate (Valparin, Encorate) — the highest teratogenicity of any psychiatric drug commonly used in women of reproductive age. First-trimester exposure carries roughly an 11% major malformation rate (vs 2–3% baseline) — neural tube defects, heart and facial defects — plus a 9–10 point average drop in childhood IQ and higher autism and ADHD rates. It should not be used in women who could become pregnant unless every alternative has failed and highly effective contraception (an IUD or implant, not condoms alone) is in place.
  • Lithium — linked to Ebstein anomaly, a rare heart defect (absolute risk roughly 1 in 1,000 vs 1 in 20,000 background). It can be continued in severe bipolar disorder with dose reduction, frequent level monitoring and fetal echocardiography, because stopping it risks postpartum psychosis. This is specialist, individualised care.
  • Carbamazepine (Tegretol) — teratogenic, usually avoided when alternatives exist; lamotrigine has a somewhat better profile.
  • Benzodiazepines — diazepam (Calmpose), alprazolam (Alprax, Restyl), clonazepam (Rivotril). Used at the lowest dose for the shortest time; late-pregnancy use can cause neonatal "floppy baby" withdrawal.
  • Z-drugs (zolpidem, zopiclone) — for sleep; generally avoided when alternatives exist. For pregnancy sleep problems, non-drug approaches come first — see our guides on pregnancy insomnia and sleep and emotional fatigue.

Note that a thyroid problem can mimic or worsen depression, so checking thyroid function is part of a good work-up — see pregnancy thyroid targets by trimester.

Continuing, stopping, switching or starting: your scenario

  • Already on an antidepressant, planning to conceive — the best time to optimise. If you are on paroxetine, valproate or another concerning drug, discuss switching before conception. If you are on sertraline or citalopram and well, you will usually continue.
  • Already on it, just confirmed pregnant — a first-trimester decision point. Sertraline, citalopram and most SSRIs are usually continued. For paroxetine, discuss switching (any first-trimester exposure has already happened). For valproate or lithium, seek urgent specialist advice.
  • Taking medicine and want to stop for the pregnancy — common, often driven by family worry. Do not stop unilaterally: if your illness has been severe or recurrent, the relapse risk is high. Weigh severity, how well the medicine works, and whether therapy alone could be enough.
  • Not on medicine but depressed during pregnancy — antenatal depression affects 10–20% of pregnant women. Mild symptoms often respond to therapy and support; moderate to severe symptoms often warrant medicine, with sertraline or citalopram first-line.
  • Severe mental illness (bipolar, schizophrenia, severe recurrent depression) — high stakes. Medicines usually need to continue or be carefully adjusted, rarely stopped, with coordinated psychiatric and obstetric care.
  • Late pregnancy approaching — decide on peripartum management: some taper the SSRI dose modestly near term, others continue steady. Neonatal adaptation, when it occurs, is usually mild and self-limiting.
  • Postpartum — the highest-risk window for relapse and new-onset depression. Plan your postpartum medicine and feeding plan during late pregnancy.

Antidepressants and breastfeeding

Breastfeeding is compatible with most antidepressants, and continuing effective treatment usually protects both you and your baby in a vulnerable period.

  • Sertraline has the most favourable lactation evidence — very low transfer into breast milk and generally well tolerated by the baby. It is often the medicine of choice if you want to breastfeed.
  • Paroxetine also has a favourable breastfeeding profile, despite its pregnancy cautions.
  • Fluoxetine transfers more into milk and stays in the infant longer, so it is less preferred while feeding if alternatives exist.

Reliable databases such as LactMed (US National Library of Medicine) carry detailed, drug-by-drug breastfeeding entries that your doctor can check. Good positioning and feeding support also help — see breastfeeding positions for Indian mothers. The key message: do not stop a medicine that is keeping you well just to breastfeed, when a feeding-compatible option usually exists.

Therapy, lifestyle and support as the foundation

Medicine is one tool. For mild to moderate symptoms, talking therapy and lifestyle support may be enough on their own; for moderate to severe illness, combining them with medicine usually works better than either alone.

  • Talking therapy — cognitive behavioural therapy (CBT) and interpersonal therapy (IPT) are both well evidenced in the perinatal period; IPT fits the role-transitions of new parenthood especially well.
  • Movement — gentle, cleared activity helps mood; see our safe pregnancy exercise guide and yoga for women's health.
  • Nutrition — adequate iron, vitamin D, B vitamins (important in vegetarian Indian diets), folate and omega-3s support mood; see postpartum nutrition.
  • Sleep, connection and support — protect sleep, lean on people, and ask directly for help; loneliness sharply raises risk. See pregnant and feeling alone and how to ask for help.
  • Partner involvement — partners shape recovery, and around 1 in 10 fathers experience perinatal depression too. If communication is strained, see when your partner doesn't understand your needs.

A word on "natural" remedies: St John's Wort, kava and some Ayurvedic preparations have limited pregnancy safety data and real interaction risks (St John's Wort interferes with many drugs, including contraceptives). "Natural" does not mean safer than a well-studied medicine.

Where to get perinatal mental health care in India

India's perinatal psychiatry network is concentrated in major teaching hospitals but expanding through telemedicine.

  • NIMHANS, Bengaluru — the leading national centre, with dedicated perinatal services, a mother-baby unit, telemedicine and subsidised (often nominal or free) care. General helpline: 080-46110007.
  • AIIMS Delhi and the wider AIIMS network, PGIMER Chandigarh, JIPMER Puducherry and CMC Vellore — perinatal mental health clinics coordinated with obstetrics.
  • Private centres — Cloudnine, Apollo, Fortis, Max, Manipal and others offer psychiatric services; perinatal specialisation varies. Expect roughly ₹1,500–5,000 per consultation.
  • Telemedicine — Practo, Apollo 247, Tata 1mg and Lybrate for psychiatry; BetterLYF, YourDOST and MindPeers for therapy. Typically ₹500–3,000 a session.

Your obstetrician is often the first point of contact — antenatal visits should include a mental-health check. If yours does not raise it, raise it yourself; our guide on depression and anxiety treatment access for Indian women explains how to navigate referrals. The Mental Healthcare Act 2017 requires insurers to cover mental health treatment on par with physical health.

Crisis support (any time you feel unsafe):
  • iCall — 9152987821 (Mon–Sat, 8 am–10 pm)
  • Vandrevala Foundation — 1860-2662-345 (24/7)
  • AASRA — 9820466726 (24/7)
  • Emergency — 112 or your nearest hospital

Myths vs facts

When to see a doctor

  • Low mood, hopelessness, persistent anxiety or loss of interest most of the day for two weeks or more
  • Any thoughts of harming yourself or your baby, or that life is not worth living — seek help the same day (iCall 9152987821, Vandrevala 1860-2662-345, or emergency 112)
  • You are taking valproate, lithium, carbamazepine or paroxetine and have just learned you are pregnant
  • You want to stop, start or switch an antidepressant — plan it with a psychiatrist rather than stopping suddenly
  • Your current dose seems to be "wearing off" as pregnancy progresses
  • Symptoms of a manic or psychotic episode (racing thoughts, no need for sleep, unusual beliefs) — these need urgent care
  • After delivery: severe low mood, intrusive thoughts, confusion or detachment from your baby

Frequently asked questions

Is it safer to just stop my antidepressant during pregnancy?

Not necessarily. Stopping suddenly can trigger relapse and withdrawal, and untreated moderate to severe depression carries real risks for both you and your baby. If you have had severe or recurrent illness, continuing is often the safer choice. Never stop on your own — plan any change with a perinatal psychiatrist.

Which antidepressant is considered safest in pregnancy?

Sertraline is generally the preferred SSRI in pregnancy and breastfeeding, with citalopram and escitalopram also considered relatively safer. The best medicine for you also depends on what has worked before, so this is an individual decision made with your doctor.

Will SSRIs harm my baby's development?

The evidence does not show that SSRIs generally cause major birth defects or developmental disability. There are small, specific associations (such as a slightly higher rate of PPHN and a mild, transient neonatal adaptation syndrome), but these are usually minor and self-limiting, and absolute risks are low.

Can I breastfeed while taking an antidepressant?

Usually yes. Most antidepressants are compatible with breastfeeding, and sertraline has especially reassuring data. Continuing an effective medicine while feeding is generally better than stopping treatment that keeps you well. Your doctor can check the specific drug in databases like LactMed.

Which psychiatric medicines must I avoid in pregnancy?

Valproate is strongly contraindicated because of high malformation and developmental risk. Lithium and carbamazepine need specialist, closely monitored use. Paroxetine and benzodiazepines are usually avoided when alternatives exist. If you take any of these and become pregnant, seek psychiatric advice urgently.

Where can I get perinatal mental health care in India?

Government and trust hospitals such as NIMHANS Bengaluru, AIIMS Delhi, PGIMER Chandigarh, JIPMER and CMC Vellore offer subsidised perinatal psychiatry. Many private hospitals and telemedicine platforms also provide care. Start with your obstetrician, and use crisis lines (iCall, Vandrevala, AASRA) any time you feel unsafe.

Sources